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Carotid intima media thickness and low high-density 
lipoprotein (HDL) in South Asian immigrants: could 
dysfunctional HDL be the missing link?
Sunita Dodani1, Lei Dong2, Faheem W. Guirgis3, Srinivasa T. Reddy4
A b s t r a c t
Introduction: South Asian immigrants (SAIs) in the US exhibit higher prev-
alence of coronary artery disease (CAD) and its risk factors compared with 
other ethnic populations. Conventional CAD risk factors do not explain the 
excess CAD risk; therefore there is a  need to identify other markers that 
can predict future risk of CAD in high-risk SAIs. The objective of the current 
study is to assess the presence of sub-clinical CAD using common carotid 
artery intima-media thickness (CCA-IMT), and its association with metabolic 
syndrome (MS) and pro-inflammatory/dysfunctional HDL (Dys-HDL). 
Material and methods: A  community-based study was conducted on 130 
first generation SAIs aged 35–65 years. Dys-HDL was determined using the 
HDL inflammatory index. Analysis was completed using logistic regression 
and Fisher’s exact test. 
Results: Sub-clinical CAD using CCA-IMT ≥ 0.8 mm (as a  surrogate mark-
er) was seen in 31.46%. Age and gender adjusted CCA-IMT was significant-
ly associated with type 2 diabetes (p = 0.008), hypertension (p = 0.012), 
high-sensitivity C-reactive protein (p < 0.001) and homocysteine (p = 0.051). 
Both the presence of MS and Dys-HDL was significantly correlated with CCA-
IMT, even after age and gender adjustment. The odds of having Dys-HDL 
with CCA-IMT were 5 times (95% CI: 1.68, 10.78). 
Conclusions: There is a need to explore and understand non-traditional CAD 
risk factors with a special focus on Dys-HDL, knowing that SAIs have low HDL 
levels. This information will not only help to stratify high-risk asymptomatic 
SAI groups, but will also be useful from a disease management point of view. 
Key words: coronary artery disease, risk factors, common carotid artery 
intima media thickness, South Asians, dysfunctional high-density lipoprotein.
Introduction
Assessment of coronary artery disease (CAD) risk relates to the avail-
ability of effective treatments that inhibit the development and progres-
sion of atherosclerosis. Effective therapeutic intervention has advanced 
the concept of primary prevention of CAD. Primary prevention focuses on 
identifying asymptomatic individuals without a prior history of CAD, who 
are at sufficiently high risk for a  future CAD event to justify gradually 
more intensive risk reduction efforts [1]. The concept of risk assessment 
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was first introduced by the Framingham Heart 
Study (FHS), and has been expanded upon in the 
decades since [2]. Risk factors routinely used in 
risk profiles or algorithms include age, blood pres-
sure, serum cholesterol (high-density lipoprotein 
(HDL) and low-density lipoprotein (LDL)), type 2 
diabetes (T2D), and cigarette smoking. Others are 
being added or considered frequently.
Assessment of common carotid artery inti-
ma-media thickness (CCA-IMT) is well recognized 
in diagnosing atherosclerosis [3]. With the use of 
high-resolution B-mode ultrasonography, one can 
evaluate early carotid atherosclerosis precisely 
and noninvasively. Of the various noninvasive im-
aging methods available, CCA-IMT measurement 
obtained with B-mode ultrasound is currently the 
only method recommended by the American Heart 
Association (AHA) for inclusion in the evaluation of 
risk [2]. Moreover, CCA-IMT is also used as a non-
invasive end point in epidemiological studies and 
clinical trials to gauge progression and regression 
of atherosclerosis [4, 5]. Furthermore, CCA-IMT has 
been used recently not only as a  surrogate end 
point for atherosclerosis of CAD but also as a good 
indicator of the presence and extent of CAD [6].
Even though CAD event rates have decreased 
by 50% in the US and other developed countries, 
event rates in South Asians (people with ancestors 
from the Indian subcontinent, i.e. India, Pakistan, 
Bangladesh, Nepal, Bhutan, and Sri Lanka) have 
doubled in the past two decades [7]. South Asian 
immigrants (SAIs) exhibit higher prevalence of 
CAD and its risk factors as compared with Cau-
casians (10% vs. 2.5%) [8, 9], and these findings 
are not limited to the US but appear to be a global 
phenomenon [10]. Although South Asians repre-
sent the second fastest growing Asian immigrant 
population in the US, little is known regarding their 
increased risk for CAD [7]. In general, the notion 
that the immigrant population carries higher risk 
for CAD also holds true for SAIs. As a whole group, 
SAIs, compared to other populations, have much 
higher prevalence of T2D, metabolic syndrome 
(MS), insulin resistance, central obesity, dyslipid-
emias [lower HDL, increased lipoprotein a (Lp[a]), 
higher triglycerides (TGs)], increased thrombot-
ic tendency, and low levels of physical activity 
[11–13]. Furthermore, CAD risk factors are pres-
ent at a younger age in South Asians compared to 
other populations, resulting in CAD at a younger 
age than in other populations [13]. However, even 
taking these differences into account, conven-
tional risk factors, insulin resistance parameters, 
or MS, although important in predicting CAD risk, 
may not fully account for the increased risk in SAIs 
[12]; thus, a search for additional markers is war-
ranted, to promote early detection and prevention 
of CAD in this high-risk group.
Among numerous genetic and lifestyle param-
eters, dyslipidemias are among the most promi-
nent risk factors for CAD. The HDL plays a  pro-
tective role in preventing CAD, and low HDL is an 
independent risk factor for CAD [14]. This protec-
tive effect of HDL is related to its role as an anti- 
atherogenic agent that prevents LDL oxidation. 
According to several recent Caucasian studies, in 
patients with CAD, HDL was found not only inef-
fective as an antioxidant but, paradoxically, ap-
pears to be a pro-oxidant, as assessed by its lipid 
peroxide content [15–17]. This pro-inflammato-
ry HDL, named as dysfunctional HDL (Dys-HDL), 
accumulates oxidants that inhibit HDL-associat-
ed antioxidant enzymes, render apolipoprotein 
A-I  (ApoA-I), the major protein of HDL, unable to 
promote ABCA1 mediated cholesterol efflux, and 
promotes the formation of LDL-derived oxidized 
lipids. According to National Cholesterol Education 
Program (NCEP) ATP III guidelines, an HDL level 
< 40 mg/dl is defined as an independent risk fac-
tor for CAD and low HDL is often present in high-
risk patients with CAD [18]. Current data indicate 
that a  1% increase in HDL serum concentration 
can reduce CV risk by 2–3%, independent of LDL 
levels [19]. However, recent studies in animals and 
humans have demonstrated that the protective 
effects of HDL are better correlated with HDL func-
tion than HDL cholesterol levels (ref). We recently 
found that 50% of participants carrying dysfunc-
tional HDL (Dys-HDL) without CAD showed a sig-
nificant association with lipoprotein [a], low HDL 
and CCA-IMT (age-adjusted) [19]. Increased CCA-
IMT measurements have been strongly associated 
with an increased risk of cardiovascular morbidity 
and mortality, as well as a marker of atheroscle-
rosis regression and dyslipidemia improvement 
in patients on lipid-lowering therapy [6]. Howev-
er, whether CCA-IMT relates to Dys-HDL, MS, and 
other CAD risk factors in SAIs is not known.
The objective of the current study was to de-
termine the association of sub-clinical CAD using 
CCA-IMT as a surrogate marker of atherosclerosis 
in SAIs with Dys-HDL and other CAD risk factors. 
Material and methods
In this cross-sectional pilot study, SAIs (South 
Asian Indians) between the ages of 35 and 65 
years were recruited from the main Hindu temples 
in the states of Georgia and Kansas. We chose 
this age because CAD and its risk factors occur at 
younger ages in SAIs as compared to other popu-
lations [8]. The SAI population in the US is most 
readily accessed through their temples of worship. 
Therefore, although study information was made 
available and distributed using different meth-
ods, the majority of the study subject recruitment 
was done through Hindu temples. This approach 
Sunita Dodani, Lei Dong, Faheem W. Guirgis, Srinivasa T. Reddy
872 Arch Med Sci 5, October / 2014
was used because there is no national level cen-
sus or data available on South Asians providing 
a correct estimate of the total population within 
the US. Therefore, we understand that the results 
of this study may not be generalizable, although 
most SAIs visit temples on weekends, represent-
ing several ethnic groups. Study information was 
made available by distributing flyers in the tem-
ples and announcements through local newspa-
pers outlining the purpose, rationale, and design 
of the study. Written informed consent and ethics 
approval was obtained from study subjects and 
the university institutional review board respec-
tively. Information on socio-demographic status, 
ethnicity (based on spoken language), personal 
lifestyle characteristics, and both traditional and 
non-traditional risk factors for CAD was obtained. 
Twelve-hour fasting blood samples were collected 
for measurements of high-sensitivity C-reactive 
protein (hsCRP), total lipid testing including total 
cholesterol, triglycerides (TGs), HDL, low-density 
lipoprotein (LDL), and lipoprotein a (Lp[a]). Insulin, 
fibrinogen, homocysteine and ApoA-I serum levels 
were also measured. 
Carotid ultrasound Doppler for common 
carotid intima-media thickness (CCA-IMT)
The CCA-IMT is defined by Pingoli et al. as the 
distance from the leading edge of the lumen-in-
tima interface of the far wall to the leading edge 
of the media-adventitia interface of the far wall 
[20]. B-mode ultrasound scanning of bilateral CCAs 
was performed by a trained non-invasive vascular 
ultrasound technician at the University of Kansas 
Medical center study clinics, using a Sonosite Mi-
croMaxx ultrasound machine (Sonosite, Inc Bothell, 
WA) with a 10.0 MHz linear array transducer. Both 
CCAs were scanned in supine position. A  total of 
eight images were obtained (four on each side), 
1 cm proximal to the carotid bulb, using a posteri-
or wall (far wall) approach. ECG leads were placed 
to obtain end-diastolic measurements. Images 
were recorded and stored on a disk. The CCA-IMT 
approach for IMT measurements was preferred be-
cause the CCA-IMT is reproducible and predictive 
of future cardiovascular events, and the data col-
lection is more complete than other non-invasive 
markers [21]. Measurements of the internal carot-
id and bifurcation segments tend to have many 
more missing values. The Mannheim Intima-Media 
Thickness Consensus suggested that measurement 
of the CCA is ideal [22].
Any focal thickening of the intima-media com-
plex or carotid plaque was not included in the 
analysis. Two cardiologists, who were blinded to 
participants’ identities and clinical information, 
analyzed stored images by using the SonoCalc 
IMT software. Measurement of the far wall of the 
carotid artery was preferred, since studies com-
paring ultrasound measurements with histology 
suggest that far-wall CCA-IMT measurements are 
more indicative of the true thickness of the arte-
rial wall [21, 22]. Near-wall CCA measurements, in 
comparison, are limited by their dependence on 
the axial resolution and gain settings of the equip-
ment used and show greater variation between 
repeated measurements [23]. Participants with 
values greater than 0.8 mm were considered to 
be IMT positive. Previous epidemiological studies 
suggest that a value of IMT at or above 0.8 mm is 
associated with a significantly increased absolute 
risk of CAD [23]. In this study a CCA-IMT value of 
0.8 mm or more was considered abnormal. CCA-
IMT values were adjusted for age as age can influ-
ence IMT [23]. We did not include carotid plaque 
in this study. 
Assessment of dysfunctional HDL (Dys-HDL)
The diagnosis of Dys-HDL has historically been 
made with a cell-based assay that requires endo-
thelial cells, smooth muscle cells, and monocytes. 
However, the use of a cell-based assay is not prac-
tical for large-scale studies. A cell-free assay has 
been developed to detect HDL that is dysfunc-
tional [24, 25]. The details on Dys-HDL assess-
ment using a cell-free assay have been published 
previously [19]. Briefly, this is a rapid test for HDL 
function that does not require cells and gives re-
sults highly comparable to those of the previously 
described cell-based assay. The HDL was isolated 
from blood samples using dextran sulfate precip-
itation. The LDL, necessary in the cell-free assay 
for testing the ability of HDL to protect against 
LDL oxidation, was prepared from a normal donor 
and was aliquoted and cryo-preserved in sucrose. 
Dichlorofluorescein-diacetate (DCFH-DA) was dis-
solved in fresh methanol at 2.0 mg/ml, incubated 
at room temperature, and protected from light for 
30  min, which resulted in the release of dichlo-
rofluorescein (DCFH) that produced an intense 
fluorescence upon interaction with oxidized lip-
id. Fluorescence was determined using a  plate 
reader (Spectra Max, Gemini XS; Molecular De-
vices) at an excitation wavelength of 485 nm, an 
emission wavelength of 530 nm, and a cutoff of 
515 nm with the photomultiplier sensitivity set 
at medium. For this study, the coefficient of vari-
ation for this assay was 9.6% [26]. Similarly, the 
HDL-inflammatory index (HII) was calculated by 
normalizing the cell-free assay values obtained 
for LDL alone as 1.0 [26]. If the addition of a test 
HDL resulted in a value of 1.0 or greater, the test 
HDL was classified as pro-inflammatory (dysfunc-
tional). Conversely, if the addition of the standard 
normal LDL together with a  test HDL resulted in 
a value less than 1.0, the test HDL was classified 
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as anti-inflammatory. To support the results of the 
cell-free assay, we also measured serum hsCRP.
Data analysis and power calculation
We enrolled 130 first generation SAIs, with dif-
ferent ethnic backgrounds. This is a  pilot study 
survey with a fixed sample of 130 participants to 
assess the Dys-HDL and sub-clinical CAD using 
CCA-IMT as a surrogate marker for atherosclero-
sis. The power calculation for assessing Dys-HDL 
was based on a  c2 contingency table analysis 
[dysfunctional HDL (Yes/No) vs. CCA-IMT (Yes/
No)], based on the available data on CCA-IMT in 
South Asians (SAs) [19, 27]. Assuming that 20% of 
130 have CCA-IMT, we have 91% power at the 5% 
a level and 85% power at the 1% a level to detect 
the Dys-HDL difference between two groups.
Statistical analysis
Baseline socio-demographic characteristics and 
CAD risk factors were summarized by frequency 
distributions and percentages for qualitative mea-
sures and means and standard deviations for quan-
titative measures. Maximum likelihood estimates 
and asymptotic 95% confidence intervals were 
calculated for the prevalence of disease/diagnosis 
outcome measures. Bivariate tests of association 
and odds ratios were performed by simple logis-
tic regression. Multiple logistic regression models 
were used to assess the relative importance of 
variables found to be significantly associated with 
the outcome from the bivariate assessments. All 
statistical tests were two-sided and performed at 
the 0.05 level of significance.
Results
Out of 130 subjects, complete information was 
obtained on 129, who thus constituted our study 
sample. The study subjects’ characteristics are 
shown in Table I. The mean age of subjects was 51 
±9.23 years with almost equal numbers of males 
and females. The study group presented a homo-
geneous mixture of various ethnicities (based on 
spoken language and ethnic background) includ-
ing Hindi speaking (18%), Gujaratis (18%), and 
South Indians (26%). More than 50% received up 
to postgraduate level education. Significant prev-
alence of CAD risk factors (Table II) was observed: 
(a) hypertension – 45%, (b) high cholesterol ≥ 200 
mg/dl – 41.6%, (c) T2D – 34.47%, (d) HDL < 40 mg/
dl – 26.4%, (e) LDL ≥ 150 mg/dl – 16.9%, (f) Lp[a] 
– 35.7%, (g) hsCRP (≥ 5) – 48.74%, (h) BMI ≥ 23 
– 78.4%, (i) obesity (BMI ≥ 30) –18.2%; (f) family 
history of CAD and T2D was 34.4% and 48.4% re-
spectively. 82.8% were physically active. Sub-clin-
ical CAD using CCA-IMT ≥ 0.8 mm (as a surrogate 
marker) was seen in 31.46%. Increased obesity is 
also reflected in increased waist circumferences in 
both genders in this study (Table II). Based on the 
Internal Diabetes Federation (IDF) definition, MS 
was seen in 29.7% of SAIs without CAD (Table II).
CCA-IMT association with CAD risk factors
The association of CCA-IMT with CAD risk fac-
tors was assessed using Fisher’s exact test. Age 
and gender adjusted CCA-IMT was significantly 
associated with T2D (p = 0.008), hypertension 
(p = 0.012), hsCRP (p < 0.001) and homocysteine 
(p = 0.051).
Dys-HDL, MS and CCA-IMT
Dys-HDL was measured by the HDL inflamma-
tory index using the cell-free assay [25]. Twenty- 
six percent (26.05%) had HDL inflammatory index 
≥ 1, suggesting pro-inflammatory HDL or Dys-HDL. 
Table I. Socio-demographic characteristics of study 
sample (n = 129)
Variable Result
Age, means ± SD [years]: 51.30 ±9.23
Male 51.04 ±9.64
Female 51.68 ±8.70
Gender, n (%):
Male 76 (58.6)
Female 53 (41.4)
Ethnicity, n (%):
South Indian 33 (25.6)
Gujarati 23 (17.8)
Hindi 23 (17.8)
Bengali 10 (7.8)
Punjabi 8 (6.2)
Other 32 (26.2)
Work type, n (%):
Employee full time 91 (70.5)
Homework 14 (10.9)
Employee part time 9 (7.0)
Unemployed 6 (4.7)
Other 8 (6.2)
Education, n (%):
Postgraduate 67 (51.9)
Graduate 30 (23.3)
Undergraduate 24 (18.6)
Other 1 (0.8)
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On Fisher’s exact test analysis, presence of both 
MS (p = 0.0348) and Dys-HDL was significantly 
correlated with CCA-IMT, even after age and gen-
der adjustment (Table III). The odds of having Dys-
HDL with CCA-IMT were 5 times (95% confidence 
interval (95% CI) 1.68, 10.78) than with those 
without Dys-HDL  (Table IV).
Discussion
Study findings presented here indicate Dys-
HDL as a possible risk factor for subclinical ath-
erosclerosis on carotid ultrasound, manifested as 
high CCA-IMT. To the best of our knowledge, thus 
is the first study showing the association of Dys-
HDL with CCA-IMT. These results further confirm 
Variable N (%) Mean ± stan-
dard deviation
BMI [kg/m2]: 26.37 ±5.08
Normal (< 23) 27 (21.62) 21.84 ±1.68
Overweight (23–30) 76 (60.14) 25.82 ±2.05
Obese (≥ 30) 22 (18.24) 34.07 ±6.45
Total LDL [mg/dl]: 117.63 ±35.61
Normal (< 150 ) 103 (83.06) 106.08 ±24.73
Abnormal (≥ 150) 21 (16.94) 174.95 ±24.44
Total HDL [mg/dl]: 48.38 ±10.99
Normal (> 40) 92 (73.6) 52.95 ±8.98
Abnormal (≤ 40) 33 (26.4) 35.79 ±4.31
Dys-HDL [mg/dl]: 0.83 ±0.74
Normal (< 1.0) 88 (73.95) 0.53 ±0.17
Dysfunctional (≥ 1.0) 31 (26.05) 1.71 ±1.02
Total cholesterol [mg/dl]: 193.17 ±38.97
Normal (< 200) 73 (58.4) 167.74 ±22.34
Abnormal (≥ 200) 52 (41.6) 229.31 ±27.37
Triglycerides [mg/dl]: 160.44 ±114.56
Normal (< 150) 73 (58.4) 99.23 ±26.88
Abnormal (≥ 150) 52 (41.6) 246.90 ±134.70
Lipoprotein [a] [mg/dl]: 13.61 ±18.99
Normal (< 10) 79 (64.23) 4.59 ±1.79
Abnormal (≥ 10) 44 (35.77) 30.02 ±24.46
Apo lipoprotein A-1: 150.36 ±31.94
Normal  
(94–176 mg/dl)
95 (76.0) 142.06 ±22.19
Abnormal  
(other values)
30 (24.0) 178.13 ±41.30
hsCRP [mg/l]: 3.32 ±2.56
Normal (< 5) 63 (51.22) 1.24 ±1.09
Abnormal (≥ 5) 60 (48.78) 5.55 ±1.60
Variable N (%) Mean ± stan-
dard deviation
Homocysteine [μmol/l]: 10.34 ±7.71
Normal (< 12) 74 (77.89) 7.96 ±2.06
Abnormal (≥ 12) 21 (22.11) 18.79 ±13.08
CCA-IMT [mm]: 0.73 ±0.16
Normal (< 0.8) 71 (68.54) 0.649 ±0.094
Abnormal (≥ 0.8) 32 (31.46) 0.916 ±0.15
Waist circumference [cm]: 93.72 ±14.08
Male 61 (48.66) 95.53 ±12.74
Female 46 (27.98) 91.47 ±15.58
Physical activity:
No 20 (15.50)
Yes 109 (84.50)
Smoking:
No 121 (93.80)
Yes 8 (6.20)
Type 2 diabetes (T2D):
No 89 (69.53)
Yes 39 (30.47)
Hypertension$:
No 70 (54.69)
Yes 58 (45.31)
Family history of T2D:
No 48 (43.24)
Yes 63 (56.76)
Family history of CAD:
No 67 (60.36)
  Yes 44 (39.64)  
MS†:
No 68 (53.1)
Yes 38 (29.7)
†MS defined by International Diabetes Federation criteria; Dys-HDL – dysfunctional HDL measured by HDL inflammatory index; hsCRP 
– high-sensitivity C reactive protein, CCA-IMT – common carotid artery intima media thickness; $history/examination and/or blood test
Table II. Coronary artery disease (CAD) risk factors and markers (n = 129)
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the findings of our previous study on Dys-HDL and 
its correlation with increased CCA-IMT in a small 
cohort of SAIs in the US, even after adjusting for 
quantitative HDL level, age, family history of CAD, 
and hypertension [19]. Normal HDL possesses an-
ti-atherogenic properties. HDL transports excess 
cholesterol from cells in artery walls to the liver 
for disposal [16, 28], removes reactive oxygen spe-
cies from oxidized (Ox)LDL, prevents OxLDL-medi-
ated recruitment of inflammatory mediators and 
monocytes into the vessel wall and inhibits endo-
thelial cell expression of adhesion molecules and 
release of hemokines/cytokines [29, 30]. Several 
components of HDL contribute to these protective 
effects, including apoA-1 and the enzyme paraox-
onase [30]. Conversely, Dys-HDL cannot prevent 
oxidation of LDL and may even further enhance 
it, leading to impairment of reverse cholesterol 
transport, increased recruitment of monocytes, 
and probably an enhanced inflammatory response 
[28]. Multiple mechanisms confer pro-inflamma-
tory characteristics on HDL molecules [31–33]. In 
acute inflammation, hepatic synthesis of the pro-
tective lipoproteins in HDL, including apoA-1 and 
antioxidant enzymes such as PON1, decreases 
[29]. Additionally, protective components in the 
HDL particles, such as apoA-1, are partly replaced 
with pro-oxidant acute phase reactants [17, 28]. 
Furthermore, HDL and apoA-1 can be readily oxi-
dized during periods of inflammation by myelop-
eroxidase, a product of white blood cell activation 
[30]; oxidation of HDL probably contributes to its 
dysfunction. 
CCA-IMT has been shown to be independent-
ly associated with CAD in South Asians [34] and 
is a  reproducible clinical tool to evaluate athero-
sclerosis, predict CAD and show the effectiveness 
of medical therapies [6, 34, 35]. However, in this 
small study we have shown that CCA-IMT can also 
predict functionality of HDL and can be instru-
mental in assessing CAD risk, especially in those 
without CAD. In one of the studies, it was found 
that IMT is inversely associated with HDL levels in 
middle aged men, but directly associated in mid-
dle aged women, as anti-atherogenic effects of 
HDL diminish in women around the age of meno-
pause [36]. However, in this study we observed an 
association of CCA-IMT with Dys-HDL in both men 
and women (not shown in the tables). In addition, 
CCA-IMT was also associated with biomarkers of 
CAD, including hsCRP and homocysteine, as well 
as risk factors of CAD, i.e. diabetes and hyperten-
sion (Table V).
Elevated homocysteine levels have attracted 
much attention in recent years as a potential risk 
factor for CVD [37, 38]. Also, higher homocysteine 
levels have been linked to carotid atherosclerosis 
as assessed by IMT [39]. The homocysteine levels 
may be determined by genetic and/or environmen-
tal factors, among which low dietary folate and 
vitamin B6 intake are important for inducing hy-
perhomocysteinemia [40]. Compared with North 
America and Europe, vegetable consumption is 
relatively high and meat consumption is relatively 
low in South Asian Hindus (South Asians belong-
ing to the Hindu religion), implying more intake of 
folate and vitamin B
6. Previous research on homo-
cysteine in South Asians is not conclusive. Many 
studies have not found any significant association 
between the two [41, 42]. To our knowledge, this 
is the first study in SAIs showing an association of 
homocysteine with CCA-IMT. However, the results 
must be interpreted with caution because of the 
small numbers studied.
Regarding MS, there is much controversy and 
contention associated with the term. Metabolic 
syndrome as a  concept was first introduced in 
Sweden in 1923, to define the association of hy-
Table III. Association of CCA-IMT (age and gender adjusted) with MS and Dys-HDL (n = 129)
Variable CCA-IMT Value of p$
< 0.8 mm ≥ 0.8 mm
MS† 0 46 (55.42) 15 (18.07) 0.0348
1 11 (13.25) 11 (13.25)
Dys-HDL HDL index < 1 48 (51.61) 16 (17.20) 0.0024
HDL index ≥ 1 12 (12.90) 17 (18.28)
CCA-IMT – common carotid artery intima media thickness; †MS – metabolic syndrome defined according to International Diabetes Federation 
criteria [Central obesity and two or more of fasting glucose (≥ 100 mg/dl or T2D), obesity, HDL (≥ 40 mg/dl), blood pressure (≥ 130/ 
≥ 85 mm Hg); and triglycerides (≥ 150 mg/day)]; Dys-HDL – dysfunctional HDL measured by HDL inflammatory index; $Fisher’s exact test
Table IV. Association of CCA-IMT (as a categorical 
variable < 0.8 mm and ≥ 0.8 mm) with MS and Dys-
HDL (n = 129)
Variable OR (95% CI) Wald X2 Value of p$
MS 3.07  
(1.11, 8.49)
3.42 0.0311
Dys-HDL 4.25  
(1.68, 10.78)
9.28 0.0023
CCA-IMT – common carotid artery intima media thickness; MS – 
metabolic syndrome defined according to International Diabetes 
Federation criteria (central obesity and two or more of fasting 
glucose (≥ 100 mg/dl or T2D), obesity, HDL (≥ 40  mg/dl), blood 
pressure (≥ 130/≥ 85 mm Hg); and triglycerides (≥ 150 mg/day)); 
Dys-HDL – dysfunctional HDL measured by HDL inflammatory 
index; OR – odds ratio; CI – confidence interval; $logistic regression
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Table V. Association of CCA-IMT (age and gender adjusted) with coronary artery disease (CAD) risk factors (n = 129)
Variable IMT Value  
of p*0 1
Age [years] > 40 10 (8.09) 2 (1.83) 0.203
≤ 40 64 (62.88) 32 (31.19)
Gender Male 44 (37.61) 20 (19.27) 0.557
Female 30 (29.36) 14 (13.76)
Smoke No 70 (63.3) 32 (31.19) 1.000
Yes 4 (3.67) 2 (1.83)
Physical activity No 9 (8.26) 8 (7.34) 0.112
Yes 65 (58.72) 26 (25.69)
Type II diabetes (T2D) No 56 (53.21) 17 (14.68) 0.008
Yes 18 (13.76) 17 (14.68)
Hypertension† No 47 (41.28) 13 (11.93) 0.012
Yes 27 (25.69) 21 (21.1)
Family history of T2D No 28 (29) 14 (14) 0.512
Yes 37 (37) 17 (20)
Family history of CAD No 40 (50) 17 (19) 0.342
Yes 25 (16) 14 (15)
Waist circumference [cm] < 90 (Male), < 80 (Female) 21 (22.99) 3 (3.45) 0.105
≥ 90 (Male), ≥ 80 (Female) 45 (50.57) 18 (22.99)
Total HDL [mg/dl] Normal (> 40) 49 (54.72) 19 (22.64) 0.136
Abnormal (≤ 40) 22 (12.26) 15 (10.38)
Total LDL [mg/dl]  Normal (< 130) 57 (55.24) 30 (29.52) 0.139
 Abnormal (≥ 130) 14 (12.38) 3 (2.86)
Triglycerides [mg/dl] Normal (< 150) 42 (38.89) 20 (20.37) 0.565
Abnormal (≥ 150) 29 (27.78) 14 (12.96)
Total cholesterol [mg/dl] Normal (< 200) 41 (34.91) 19 (18.87) 0.511
Abnormal (≥ 200) 30 (32.08) 15 (14.15)
Apo lipoprotein A-1 Normal (94–176) 56 (52.83) 23 (21.7) 0.089
Abnormal 13 (14.15) 12 (11.32)
Lipoprotein [a] [mg/dl] Normal (< 10) 46 (44.76) 16 (16.19) 0.087
Abnormal (≥ 10) 25 (22.86) 17 (16.19)
hsCRP [mg/l] Normal (< 5) 42 (40.2) 6 (6.86) < 0.001
Abnormal (≥ 5) 29 (27.45) 26 (25.49)
Homocysteine [μmol/l] Normal (< 12) 42 (53.25) 20 (25.97) 0.051
Abnormal (≥ 12) 13 (18.18) 1 (2.6)
n (%); hsCRP – high-sensitivity C reactive protein; †History/examination;*Fisher’s exact test 
perglycemia, hypertension and gout [43]. The ma-
jority of SAIs (preferably South Asian Indians) have 
a smaller body habitus compared to Caucasians. 
Obesity, by its classic definition, is rare among 
SAIs [44], as seen in this study as well (Tables II 
and V). The new International Diabetes Federa-
tion (IDF) definition attempted to compensate (to 
a very limited extent) for this flaw by recognizing 
a different set of measurements to define abdom-
inal obesity in different Asian ethnic groups from 
the different regions in the Asian continent [45]. 
It is widely recognized that there are variations in 
the combinations of different metabolic derange-
ments in different populations groups, which can 
lead to a wide array of disease outcomes, of which 
the majority are cardiovascular in nature. Thus, it 
is clear that the traditional definitions of MS still 
fail to be representative of South Asian Indian eth-
nicity. It is interesting to note that the convention-
al descriptions of MS have no mention of genetic 
factors that serve as CAD risk markers. In defining 
the MS unique to the Asian Indian, it is import-
ant to recognize the accelerated progression of 
coronary atherosclerosis, leading to myocardial 
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infarction at a younger age. The unique constel-
lation of known metabolic risk factors that predis-
poses the SAIs to CAD and its manifestation early 
in life can be identified early in life. The distinct 
features of this MS with accelerated atheroscle-
rosis in the SAIs include visceral adiposity, insulin 
resistance/hyperinsulinemia, high LP(a) levels, low 
HDL levels, and high homocysteine levels. The cur-
rent study also confirmed the findings of an earli-
er study showing significant prevalence of MS in 
SAIs, including a high burden of CAD risk factors. 
In addition, MS was significantly associated with 
CCA-IMT. Many risk factors are associated with ca-
rotid atherosclerosis, and several epidemiological 
studies have demonstrated that MS is an indepen-
dent risk factor for carotid atherosclerosis [46–
48]. Consistent with previous findings, the current 
study found that CCA-IMT was significantly great-
er in subjects with MS than in those without. Fur-
thermore, the results of our study are consistent 
with those of previous studies that have found 
a trend toward increased CCA-IMT with increasing 
numbers of components of MS (Table V). Kanaya 
et al. also found an association of CCA-IMT with 
MS in SAIs in a  study that was designed based 
on MESA (Multi-Ethnic Study of Atherosclerosis) 
study methods [49].
First, the study design was cross-sectional, so 
caution should be exercised in any causal inter-
pretation of CCA-IMT and the CAD parameters. 
Additionally, longitudinal effects of Dys-HDL, MS 
and other CAD risk factors on the progression of 
CCA-IMT were not evaluated. A second limitation 
of our study is the small sample size due to limited 
funding. Further longitudinal studies are needed 
to support findings in the larger SAI population. 
Third, the convenience sample of the study may 
cause selection bias. We recruited participants 
from local Hindu temples, and therefore partici-
pants may not be completely representative of the 
South Asian Indian community. There are no cen-
sus data on SAIs within the US that provide a true 
estimate of the SAI population, and the conve-
nience sampling method is mostly used to design 
studies in SAIs. However, people attending these 
temples were from mixed ethnic backgrounds, and 
data were collected from participants who attend-
ed weekend worship services, which in general 
are attended by SAI Hindus from different and di-
verse ethnic groups. Therefore, we anticipate that 
the selection bias is minimal and that the sample 
is representative of SAI Hindus. Third, we did not 
assess diet in this study, and we plan to include 
a detailed nutrition component in our larger study. 
Fourth, due to the limited budget and in order to 
have a homogeneous group, we only included Hin-
du SAIs, and SAs of different religions were not 
included. And last but not the least, we were not 
able to do further special tests, and, since this was 
a small sample size, we were not able to make any 
definitive conclusions regarding the association of 
Dys-HDL with CAD and its risk factors. Although 
this study used the presence of CCA-IMT as an 
outcome variable, more precise analyses must use 
characteristics of plaques (volume, height, and 
echogenicity) rather than merely the presence of 
CCA-IMT as an outcome.
In conclusion, this study is the first of its kind 
assessing the association of sub-clinical CAD us-
ing carotid IMT as a surrogate marker of athero-
sclerosis with Dys-HDL in SAIs. Given that SAIs are 
known to carry a disproportionately high risk for 
CAD, there is a  need to explore and understand 
non-traditional risk factors. The SAs in general and 
SAIs in particular are known to have low HDL. This 
study has also highlighted the presence of Dys-
HDL in this high risk group. Therefore, not only 
HDL quantity but also HDL quality and function 
are important for CAD future prediction. A major 
challenge associated with primary prevention of 
CAD in SAIs involves the early and accurate de-
tection of CAD in high-risk but asymptomatic in-
dividuals, to prevent coronary events. CCA-IMT is 
a non-invasive surrogate marker of atherosclerosis 
and is proven to be helpful in detecting sub-clini-
cal CAD by stratifying populations at highest risk 
for CAD. The results of this study further suggest 
that health education and rehabilitation programs 
need to be designed specifically for this high-risk 
group, would be beneficial when initiated early in 
life, and need to be targeted at the individual. Al-
though the major modifiable risk factors do not 
fully explain the excess burden of CAD, they are 
doubly important and remain the foundation of 
preventive and therapeutic strategies in this pop-
ulation. A more aggressive approach to preventive 
therapy, especially dyslipidemia, at an earlier age 
and at a lower threshold, is clearly warranted. In 
addition, determining the presence of Dys-HDL in 
SAIs will answer several questions related to the 
presence of altered HDL level and function. Fur-
ther research, including longitudinal prospective 
studies, is required to support the current study 
findings with investigation of the temporal asso-
ciation. 
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